在肥胖患者中比较两种万科米辛加载剂量方案:单中心前性临床试验
William Payne1, Stephanie Thompson2, Brian N Burton2
1Emergency Medicine, Charleston Area Medical Center, Charleston, USA.
Cureus
|November 4, 2024
概括
对肥胖患者 (PwO) 来说,更高的万科米辛剂量 (高达4000毫克) 是安全有效的,在不增加脏不良事件的情况下达到治疗性药物度. 这项研究支持为这一群体优化万科米辛剂量策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 传染性疾病 传染性疾病
背景情况:
- 肥胖症显著改变药物的药理动力学,需要为肥胖患者 (PwO) 量身定制的万科米辛剂量.
- 确保治疗性万科米辛水平对于普华永道的有效治疗和患者安全至关重要.
研究的目的:
- 为了比较PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.PwO.
- 评估血清中万科米辛度和对肥胖患者功能的影响.
主要方法:
- 一项前性单中心研究将成年PwO (体重>100公斤) 随机分为两组.
- 第1组接受了20 mg/kg的万科米辛充填剂量,最高2000 mg;第二组接受了相同的充填剂量,最高4000 mg.
主要成果:
- 与2000毫克组相比,4000毫克组达到显著更高的万科米辛低谷和峰值度.
- 在高剂量组中,脏不良结果,住院或死亡率没有显著增加.
- 治疗性万科米辛度在4000毫克的最大剂量下得到更一致的达到.
结论:
- 在PwO中,更高的万科米辛加载剂量 (高达4000毫克) 耐受性很好.
- 这些较高的剂量不会对功能产生短期不良影响.
- 需要进行进一步的研究,以确定针对肥胖患者的万科米辛剂量指南.
相关概念视频
Rational Dosage Regimen: Maintenance Dose and Loading Dose
3.9K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
3.9K
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
62
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
62
Two-Compartment Open Model: IV Bolus Administration
407
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
The disparity between drug input and the sum of drug transfer rates between...
407
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
213
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
213


